Overview
David E. Albert, MD, is a founder and chief medical officer of AliveCor, a company building personal electrocardiogram technology including KardiaMobile devices and AI-supported cardiac analysis software. AliveCor’s leadership biography describes Albert as an Oklahoma native, physician, inventor, and serial entrepreneur who has developed life-saving technologies over the last 30 years. He is a founder of three technology companies: InnovAlarm, Lifetone Technology, and AliveCor.
Albert’s latest invention, AliveCor’s KardiaMobile personal ECG technology, became a global sensation via a YouTube video in January 2011 around the Consumer Electronics Show and was featured on ABC, CBS, CNN, and Fox News among many media outlets per his official biography.
Role and company
As Founder and Chief Medical Officer, Albert provides clinical and inventive leadership across AliveCor’s device portfolio — including KardiaMobile 6L, Kardia 12L, and KardiaStation software — and AI-supported analysis products. AliveCor markets personal EKGs, provider platforms such as KardiaPro and KardiaStation, and API solutions for life sciences and health-system partners.
Albert’s biography states he has 80 issued U.S. patents, a large number pending, and several new secret inventions in development, with over 100 scientific abstracts and publications principally in cardiology literature.
Background and career context
Albert graduated with honors from Harvard College and from Duke University Medical School per AliveCor’s leadership biography. His previous startups include Corazonix Corp (sold to Arrhythmia Research Technology) and Data Critical (sold to GE). He left GE in 2004 as Chief Scientist of GE Cardiology to disrupt new markets.
Albert has lectured at entrepreneurship programs at the MIT Sloan School and the University of Oklahoma per his official biography — reflecting his public role bridging clinical invention and commercialization education.
Company-building or leadership context
Albert founded AliveCor after decades of cardiology technology entrepreneurship. The 2011 Consumer Electronics Show KardiaMobile demonstration established consumer-accessible ECG recording as a product category distinct from hospital-grade telemetry. AliveCor subsequently pursued FDA clearances, CPT coding, and health-system partnerships building on Albert’s inventor-founder credibility.
As CMO rather than CEO, Albert’s ongoing role emphasizes clinical validation and product invention while operational leadership sits with AliveCor’s executive team per company leadership disclosures.
Public milestones
AliveCor’s leadership biography documents Albert’s 2011 CES KardiaMobile viral launch and extensive media coverage. Albert holds 80 issued U.S. patents per the cited page. AliveCor has expanded its device portfolio and AI analysis software with multiple FDA-cleared offerings referenced on alivecor.com product pages reviewed in 2026.
Albert’s publication record — over 100 scientific abstracts and publications — supports AliveCor’s clinical marketing to cardiologists evaluating personal ECG adoption.
Why their work matters
AliveCor under Albert’s inventive leadership helped normalize personal ECG screening outside traditional cardiology office workflows — a patient-access expansion later competitors and health systems studied when evaluating consumer cardiac AI. Physician-inventor founders like Albert bring clinical credibility that pure software entrepreneurs often lack in FDA-regulated device categories.
For healthcare AI readers, AliveCor bridges hardware, cloud AI, and outpatient screening — a different deployment model than hospital imaging AI or ambient documentation platforms.
Sources and references
Primary sourcing: AliveCor David E. Albert, MD leadership biography, reviewed July 10, 2026.
- AliveCor — David E. Albert, MD (alivecor.com)
- AliveCor — About (alivecor.com)
Patent counts, education, and prior company exits sourced only from AliveCor leadership biography. No unverified valuation claims included.